MedExecWomen Invites Women in Life Sciences to Join the 2021 Annual Conference in Boston in October

MedExecWomen, a non-profit organization focused on empowering female executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world, is hosting the second MedExecWomen Annual Conference for women in the life sciences industry later this month in Boston. This year’s conference will be in person on Oct. 26, 2021, at the Sheraton Boston in Back Bay and registration is now open.

The upcoming conference, Medical Innovation in a Post-Covid World, will be a one-day meeting featuring expert panelists — some of the top physicians and leaders in the life science and medical device industries — discussing the state of the market and several of the biggest ongoing industry challenges and how to overcome them, including:

  • Analyst opinions on the state of the medtech sector
  • COVID changes for how medtech companies lead global organizations and expand commercial operations
  • Where inpatient procedures are going
  • Inequities in healthcare spanning clinical trial participation, patient education and hesitancy, healthcare delivery, and access
  • How to become a board member
  • Ongoing innovation in digital health technologies
  • Healthcare financial pressure due to COVID and ongoing hospital operational practices

“You’ll be joining as many as 150 executive life science women to dig deeper into these important topics and have conversations with experts across the industry,” said Co-founder of MedExecWomen and President and Founder of Medi-Vantage, Maria Shepherd. “There are so many challenges now and into 2022, and we expect even more change in this new normal. In Boston, our medtech expert panelists are going to provide some real insight into what they foresee.”

Full COVID precautions, including masking, ensuring that all registrants are fully vaccinated, and social distancing are being taken to ensure your safety at this important meeting.

Interested in attending? Registration is open at: https://medexecwomen.org/store/p/medexecwomen-annual-conference-2021.

A full agenda is available at: https://medexecwomen.org/2021-agenda.

 

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.